AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

RDGT · NASDAQ · Medical - Distribution

Ridgetech (RDGT)

China-focused B2B pharmaceutical wholesale and online distributor.

$0.9765

Pre-market+0.02 (+2.44%)

At close$0.9532(+2.08%)

Watchlist

In millions of USD, except per-share figures

In millions	Q3 FY21Dec 2020	Q4 FY21Mar 2021	Q2 FY22Sep 2021	Q4 FY22Mar 2022	Q2 FY23Sep 2022	Q4 FY23Mar 2023	Q2 FY24Sep 2023	Q4 FY24Mar 2024	Q2 FY25Sep 2024	Q4 FY25Mar 2025	Q2 FY26Sep 2025	Q4 FY26Mar 2026
Revenue	36	36	78	86	73	76	79	76	71	49	63	69
Cost of revenue	27	30	63	65	56	59	63	61	57	60	60	67
Gross profit	8	6	15	21	17	17	16	15	15	−11	2	2
	14	7	16	23	18	37	16	19	17	−12	2	4
	14	6	16	23	18	37	16	19	17	−12	3	4
Selling & marketing	8	6	13	18	15	15	14	6	14	−13	1	0
General & administrative	6	1	3	6	4	22	2	13	3	1	1	0
Other expenses	0	0	0	0	0	0	0	0	0	0	0	0
Operating income	−6	−1	0	−2	−1	−20	0	−4	−2	1	0	−2
	0	0	0	0	1	−1	−1	1	0	0	0	0
Interest income	0	0	0	0	0	1	0	0	0	0	0	0
Interest expense	0	0	0	0	0	0	0	0	0	0	0	0
Other non-operating income	0	0	0	0	0	0	0	0	0	0	0	0
Income before tax	−6	0	0	−2	0	−21	−1	−3	−2	1	0	−1
Income tax expense	0	0	0	1	0	0	0	0	0	0	0	0
Net income from continuing operations	−6	0	0	−3	−1	−21	−1	−3	−2	1	0	−1
Discontinued operations	0	0	0	0	0	0	0	0	0	12	0	0
Net income	−6	0	0	−3	−1	−21	−1	−3	−2	12	0	−1
EPS, basic	−$810,000.00	−$18,000.00	−$34,200.00	−$378,900.00	−$58,950.00	−$582,750.00	−$17,550.00	−$44,100.00	−$9,450.00	$9,571,950.00	−$231.75	−$1.34
EPS, diluted	−$810,000.00	−$18,000.00	−$54,000.00	−$378,900.00	−$58,950.00	−$582,750.00	−$17,550.00	−$44,100.00	−$9,450.00	$50,850.00	−$231.75	−$1.34
Weighted average shares, basic	0	0	0	0	0	0	0	0	0	0	0	1
Weighted average shares, diluted	0	0	0	0	0	0	0	0	0	0	0	1
EBITDA	−6	0	0	−2	−1	−20	1	−3	−2	7	0	−2
Depreciation & amortization	0	0	1	1	1	0	0	0	1	6	0	0
EBIT	−6	0	0	−2	−1	−20	0	−4	−2	1	0	−2